canSAR

Cancer translational knowledge base integrating pharmacology, bioactivity, structure, druggability.

Composite
89.4
Experimental validation
Wet-lab confirmed
Stages
Target IDHit ID
Modalities
small-moleculeprotein-general
Task types
druggabilitytarget-annotation
Size
proteins: 25,000
compounds: 11,000,000
bioactivity_datapoints: 106,000,000
License
Academic free / commercial tier
First release
2011
Last updated
2024-09
Official site
→ project page
Leaderboard
→ leaderboard
Dataset
→ dataset
Code / GitHub
→ repository
HuggingFace
→ HF
Paper
canSAR: update to the cancer translational research and drug discovery knowledgebase · Mitsopoulos C, Di Micco P, et al. · 2021 · paper · doi:10.1093/nar/gkaa1059 · 210 citations
Flags
none
Experts
Bissan Al-Lazikani
Groups
The Institute of Cancer Research
Hosted by
Related benchmarks
Open Targets Platform, DepMap (Cancer Dependency Map), ChEMBL

Rubric (7-criterion)

rigor
5
coverage
5
maintenance
4
adoption
4
quality
5
accessibility
3
industry_relevance
5

Notes

Deep oncology focus; widely-used druggability predictor.

← Back to all benchmarks

Compare:
Open comparison →